<DOC>
	<DOCNO>NCT02776059</DOCNO>
	<brief_summary>This multi-center , prospective , randomize trial standard care vs. standard care + pegfilgrastim ( Neulasta® ) among patient clinical diagnosis alcoholic hepatitis DF≥32 .</brief_summary>
	<brief_title>Pegfilgrastim Patients With Alcoholic Hepatitis</brief_title>
	<detailed_description>Standard care treatment either prednisolone 40 mg/day 28 day pentoxifylline 400 mg TID 28 day . The patient 's physician decide standard care treatment patient receive . Patients randomize ( 1:1 ) receive either additional drug treatment ( SOC group ) receive pegfilgrastim ( Neulasta® , 6 mg ) SQ . Patients see in-person screening , randomization ( Day 1 ) , Day 8 , Day 29 , Week 12 , Week 24 . Safety examination blood test perform . In addition , biological specimen save research purpose time point . Total duration patient participation 24 week .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>A clinical diagnosis alcoholic hepatitis Maddrey 's discriminant function score ≥32 . Age 18 year old . Renal failure ( creatinine &gt; 2.0 mg/dl ) Bilirubin &lt; 5 mg/dL uncontrolled recent upper gastrointestinal bleeding Known HIV infection Uncontrolled infection , pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>survival</keyword>
	<keyword>pegfilgrastim</keyword>
	<keyword>cirrhosis , alcoholic</keyword>
</DOC>